首页> 外文期刊>Radiology >Chemotherapy-induced focal hepatopathy in patients with gastrointestinal malignancy: Gadoxetic acid-enhanced and diffusion-weighted MR imaging with clinical-pathologic correlation
【24h】

Chemotherapy-induced focal hepatopathy in patients with gastrointestinal malignancy: Gadoxetic acid-enhanced and diffusion-weighted MR imaging with clinical-pathologic correlation

机译:胃肠道恶性肿瘤患者化疗所致的局灶性肝病:葡萄糖酸增强和弥散加权MR成像与临床病理相关性

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose: To retrospectively evaluate findings of chemotherapyinduced focal hepatopathy (CIFH) on gadoxetic acid- enhanced magnetic resonance (MR) and diffusion-weighted (DW) images and to determine imaging features that are most helpful in differentiating CIFH from metastasis. Materials and Methods: This retrospective study was approved by the institutional review board, and informed consent was waived. MR images, including DW images and gadoxetic acid-enhanced images, from 12 patients (four men, eight women; age range, 25-64 years) with 15 CIFHs were reviewed independently and in consensus by two radiologists and were compared with those obtained in 20 control patients (12 men, eight women; age range, 32-84 years) with 30 hepatic metastasis who were matched for tumor size, primary organ, and chemotherapy regimen. Interobserver agreement was assessed with κ statistics, and univariate analysis was performed for comparisons. For quantitative analyses, apparent diffusion coefficients (ADCs) and lesion-to-liver contrast ratios (CRs) were measured. Histopathologic examinations were performed for CIFHs. Results: Histopathologic examination revealed that the development of CIFHs was attributable to accentuated manifestations of sinusoidal obstruction syndrome. Interobserver agreement was excellent (κ > 0.85). An ill-defined margin on hepatobiliary phase (HBP) images was the most discriminating independent variable in the differentiation of CIFH from metastasis (odds ratio, 16; P = .009). ADC and CR values in CIFH group were significantly higher than those in metastasis group (P < .001 and P = .041). Conclusion: CIFH should be considered a mimicker of metastasis in patients with gastrointestinal malignancy during chemotherapy. CIFH can be differentiated from metastasis on the basis of gadoxetic acid-enhanced MR and DW imaging findings; an ill-defined margin on HBP images was especially characteristic.
机译:目的:回顾性评估在牛ado酸增强磁共振(MR)和弥散加权(DW)图像上化疗引起的局灶性肝病(CIFH)的发现,并确定最有助于区分CIFH和转移的影像学特征。材料和方法:这项回顾性研究已获得机构审查委员会的批准,并放弃了知情同意。两名放射科医生独立并一致地对来自15例CIFH的12例患者(四名男性,八名女性;年龄范围为25-64岁)的MR图像(包括DW图像和牛磺酸增强图像)进行了比较,并将其与在20例具有30例肝转移的对照患者(男12例,女8例;年龄范围32-84岁)符合肿瘤大小,主要器官和化疗方案。观察者之间的一致性通过κ统计量进行评估,并进行单变量分析以进行比较。对于定量分析,测量了表观扩散系数(ADC)和病灶与肝脏的对比度(CR)。对CIFH进行了组织病理学检查。结果:组织病理学检查显示,CIFHs的发展归因于窦性阻塞综合征的加重表现。观察者之间的一致性非常好(κ> 0.85)。肝胆期(HBP)图像上边缘不明确是区分CIFH和转移的最有区别的独立变量(比值比为16; P = 0.009)。 CIFH组的ADC和CR值显着高于转移组(P <.001和P = .041)。结论:CIFH应被认为是化疗期间胃肠道恶性肿瘤转移的一个小窍门。根据加多西酸增强的MR和DW影像学发现,可以将CIFH与转移区别开来; HBP图像上的边界不明确尤其突出。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号